Trial intelligence / Profile preview

Naltrexone for heavy drinkers seeking smoking cessation

NCT00938886Phase 2Completed

Sponsor
Brown University
Start
Oct 2009
Primary completion
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of naltrexone in hazardous drinking, Tobacco Use Disorder (TUD), sponsored by Brown University. Started Oct 2009; status: completed.

02

Drugs

naltrexone
03

Conditions

hazardous drinkingTobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT00938886.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00938886.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call